2nd Annual Molecular Diagnostics Summit
Time：2014-08-14 -08-15location：tianjin tianjinshi
Molecular diagnostics emerged as the rapidly growing industry in the world IVD market with 20 years development. Applications to fast diagnosis of infectious disease, early diagnosis of oncology and newborn screening have been the hotspots which scientists and manufacturers are focusing on.
Infectious disease testing and blood screening have pushed the development of clinical molecular diagnostics. The rising morbidity rate of HIV and viral hepatitis indicates that China is facing severe situation on infectious diseases’ prevention and control. Meanwhile, the rising numbers of HIV patients together with promotion of nucleic acid-based molecular diagnostics of blood screening have brought huge market. Besides, benefiting from economics development, healthcare improvement and gene chip and NGS technologies development, companion diagnostics and personalized diagnostics of oncology, hereditary disease detection, pharmacogenomics and 4P(Preventive，Predictive，Personalized，Participatory) medical model will show strong development trends in next 10 years.
2nd Annual Molecular Diagnostics Summit (MDx 2014) will deeply discuss the market trends, corporations’ collaboration, technology platforms development and application, and personalized treatment. We look forward to have you onsite and discuss the molecular diagnostics’ yesterday, today and tomorrow.
Event Highlights
- Explore new regulatory policies in China
- Network with an international delegation of thought leaders
- Discover better technologies and products
- Hear future perspectives on clinical applications